PFS Group Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • PFS Group's estimated annual revenue is currently $142.1M per year.(i)
  • PFS Group's estimated revenue per employee is $337,500

Employee Data

  • PFS Group has 421 Employees.(i)
  • PFS Group grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.6M3540%N/AN/A
#2
$9.9M4615%N/AN/A
#3
$7.6M3513%N/AN/A
#4
$28.9M10735%N/AN/A
#5
$5.1M27-23%N/AN/A
#6
$6.7M310%N/AN/A
#7
$4.2M22-19%N/AN/A
#8
$9.5M44-8%N/AN/A
#9
$10.8M500%N/AN/A
#10
$10.6M49-2%N/AN/A
Add Company

PFS Group provides accounts receivable enhancement programs that are custom-designed for each client's individual needs. Our experienced professionals communicate with your patients to provide a compassionate account resolution experience, while improving your hospital's return on investment. PFS Group’s dedication to superior customer service helps maintain your excellent reputation throughout the patient community and healthcare industry. \r\n\r\nOur services include: patient balance management, insurance accounts receivable management, conversion assistance programs and interim management. \r\n\r\nMaximizing customer satisfaction while improving your bottom line, we deliver personal service with patients’ needs in mind. PFS Group — where experience counts.

keywords:N/A

N/A

Total Funding

421

Number of Employees

$142.1M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PFS Group News

2022-04-20 - Up-Front HDT Consolidation Beneficial in Myeloma With High ...

... high-risk group benefited most from the regimen (P = .03). Additionally, the hazard ratios for progression-free survival (PFS) for HDT...

2022-04-20 - Tewari Reviews Maintenance Treatments for Patients With ...

But in the BRCA group, we had a doubling PFS.5 You wonder, “If these drugs are so similar, why are we seeing 56 months [with olaparib] vs 22...

2022-03-30 - Rubraca extends PFS as maintenance therapy in ovarian ...

Among women with HRD-positive tumors, results showed significantly longer PFS by investigator review in the rucaparib group (n = 185) compared...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$128.9M42130%N/A
#2
$162.1M4211%N/A
#3
$184.6M42223%N/A
#4
$111.8M42666%N/A
#5
$155.2M42822%N/A